Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP).

Full DD Report for ORMP

You must become a subscriber to view this report.


Recent News from (NASDAQ: ORMP)

Oramed to Present at the H.C. Wainwright Global Investment Conference
NEW YORK , Aug. 28, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) ( www.oramed.com ),  a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming H....
Source: PR Newswire
Date: August, 28 2018 08:25
Oramed Granted Japanese Patent for GLP-1 Analog Capsule
NEW YORK , July 24, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office has publici...
Source: PR Newswire
Date: July, 24 2018 08:25

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-144.954.954.994.9512,116
2018-08-204.754.804.804.6817,595
2018-08-174.71354.734.814.689,773
2018-08-164.764.764.824.6622,733
2018-08-154.934.764.944.7126,466

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-149,11011,01082.7430Short
2018-12-136,08011,83451.3774Short
2018-12-1215,28120,69873.8284Short
2018-12-114,7546,84869.4217Short
2018-12-101,0701,87057.2193Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ORMP.


About Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP)

Logo for Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP)

Oramed Pharmaceuticals OTC:ORMP.OB is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase trials, the Company is seeking to revolutionize the treatment of diabetes.

 

Contact Information

 

 

Current Management

  • Nadav Kidron / President, CEO
  • Miriam Kidron / CSO, CTO
  • Yifat Zommer / CFO, Treasurer, Secretary
  • Aviva Sherman / Corp. Commun., Executive Assistant
  • Miriam Kidron /
  • Nadav Kidron /

Current Share Structure

  • Market Cap: $109,186,683 - 05/18/2018
  • Issue and Outstanding: 14,442,683 - 04/06/2018

 


Recent Filings from (NASDAQ: ORMP)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 30 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: July, 30 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: July, 20 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: July, 20 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: July, 13 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: July, 12 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: July, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 05 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: July, 05 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: July, 03 2018

 

 


Daily Technical Chart for (NASDAQ: ORMP)

Daily Technical Chart for (NASDAQ: ORMP)


Stay tuned for daily updates and more on (NASDAQ: ORMP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ORMP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ORMP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ORMP and does not buy, sell, or trade any shares of ORMP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/